Meghan Fitzgerald, Director at Roivant Sciences Ltd. (ROIV), sold 20,000 shares at $39.90 ($798K) on 2026-09-08, disclosed to the SEC on 2026-09-10.
Scheduled sale ($798k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| THC | SELL | 2024-08-08 | $2.9M | — | Filing → |
| THC | SELL | 2021-09-20 | $884K | — | Filing → |
| THC | SELL | 2021-05-26 | $782K | — | Filing → |